FGF23 and chronic kidney disease: However, in the early stages of CKD, downregulation of klotho occurs due to loss of viable tissue, albuminuria, and activation of the Wnt/β-Catenin signaling pathway; therefore, elevated FGF-23 cannot function, leading to FGF-23 resistance [27,28,31].